drugset / Trial / NCT00499642
Study Evaluating the Effect of Lecozotan SR on the QTc Interval
RandomizedCrossoverDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo- and moxifloxacin (open-label)-controlled, 4-period crossover study.
Timeline
- Start
- 2007-06
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lecozotan | Small molecule | — | — |
| Subject | Moxifloxacin | Small molecule | — | — |